NL8602282A - Carbapenem-antibiotica. - Google Patents

Carbapenem-antibiotica. Download PDF

Info

Publication number
NL8602282A
NL8602282A NL8602282A NL8602282A NL8602282A NL 8602282 A NL8602282 A NL 8602282A NL 8602282 A NL8602282 A NL 8602282A NL 8602282 A NL8602282 A NL 8602282A NL 8602282 A NL8602282 A NL 8602282A
Authority
NL
Netherlands
Prior art keywords
formula
group
alkyl
pharmaceutically acceptable
methyl
Prior art date
Application number
NL8602282A
Other languages
English (en)
Dutch (nl)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NL8602282A publication Critical patent/NL8602282A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NL8602282A 1985-09-11 1986-09-10 Carbapenem-antibiotica. NL8602282A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77462885 1985-09-11
US06/774,628 US4665169A (en) 1985-09-11 1985-09-11 Carbapenem antibiotics

Publications (1)

Publication Number Publication Date
NL8602282A true NL8602282A (nl) 1987-04-01

Family

ID=25101800

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8602282A NL8602282A (nl) 1985-09-11 1986-09-10 Carbapenem-antibiotica.

Country Status (31)

Country Link
US (1) US4665169A (zh)
JP (1) JPS6261980A (zh)
KR (1) KR910006807B1 (zh)
CN (1) CN1015261B (zh)
AR (1) AR242577A1 (zh)
AT (1) AT396472B (zh)
AU (1) AU596990B2 (zh)
BE (1) BE905415A (zh)
CH (1) CH669381A5 (zh)
CS (1) CS259892B2 (zh)
DD (1) DD252605A1 (zh)
DE (1) DE3630857C2 (zh)
DK (1) DK433586A (zh)
ES (1) ES2002303A6 (zh)
FI (1) FI81803C (zh)
FR (1) FR2587704B1 (zh)
GB (1) GB2180238B (zh)
GR (1) GR862313B (zh)
HU (1) HU198491B (zh)
IL (1) IL79969A0 (zh)
IT (1) IT1207578B (zh)
LU (1) LU86575A1 (zh)
MY (1) MY102957A (zh)
NL (1) NL8602282A (zh)
NZ (1) NZ217519A (zh)
PT (1) PT83361B (zh)
SE (1) SE469630B (zh)
SU (1) SU1480764A3 (zh)
YU (1) YU45800B (zh)
ZA (1) ZA866638B (zh)
ZW (1) ZW16186A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5321020A (en) * 1989-03-28 1994-06-14 Pfizer Inc. Antibacterial 2-carbapenem derivatives
HUT63167A (en) * 1989-03-28 1993-07-28 Pfizer Process for producing antibacterial 2-carbapenem derivatives and pharmaceutical compositions comprising same as active ingredient
US5602118A (en) * 1993-03-16 1997-02-11 American Cyanamid Company 2-thiosubstituted carbapenems
RU2714730C1 (ru) 2019-04-11 2020-02-19 Общество с ограниченной ответственностью "КС-ТЕХНОЛОГИИ" Конусная инерционная дробилка с опорным подшипником скольжения

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950357A (en) * 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics
US4235920A (en) * 1975-11-21 1980-11-25 Merck & Co., Inc. N-Alkylated derivatives of thienamycin
AU531084B2 (en) * 1977-10-19 1983-08-11 Merck & Co., Inc. Azetidine derivatives
AU4061378A (en) * 1977-10-19 1980-04-17 Merck & Co., Inc. 1-azabicyclo (3.2.0) hept-2-enes
US4232036A (en) * 1978-10-24 1980-11-04 Merck & Co., Inc. 6-, 1- and 2-Substituted-1-carbadethiapen-2-em-3-carboxylic acids
DE2966497D1 (en) * 1978-10-24 1984-01-26 Merck & Co Inc 6-, 1- and 2-substituted-1-carbapen-2-em-3-carboxylic acids, processes for the preparation of such compounds and pharmaceutical composition comprising such compounds
DK165280A (da) * 1979-04-19 1980-10-20 Merck & Co Inc Fremgangsmaade til fremstilling af 2- og 6-substituerede 1-carbadethiapen-2-em-3-carboxylsyrer og mellemprodukter til brug ved udoevelse af fremgangsmaaden
US4376774A (en) * 1979-05-29 1983-03-15 Merck & Co., Inc. Antibiotic N-heterocyclyl thienamycin
IE52147B1 (en) * 1980-03-27 1987-07-08 Merck & Co Inc 4-(3-carboxy-2-oxopropyl)-azetidin-2-ones and process for their preparation
EP0037082B1 (en) * 1980-03-27 1985-03-20 Merck & Co. Inc. Process for the preparation of 1-carbapenems and intermediates via silyl-substituted dithioacetals
US4309346A (en) * 1980-03-27 1982-01-05 Merck & Co., Inc. Process for the preparation of 1-carbapenems and intermediates via trithioorthoacetates
EP0038869A1 (en) * 1980-04-30 1981-11-04 Merck & Co. Inc. Process for the preparation of 1-carbapenems, and intermediates for their preparation
JPS56161393A (en) * 1980-05-16 1981-12-11 Sanraku Inc Beta-lactam compound
CA1198440A (en) * 1982-04-08 1985-12-24 Choung U. Kim Carbapenem antibiotics
US4552696A (en) * 1982-04-09 1985-11-12 Bristol-Myers Company Carbapenem antibiotics
US4536335A (en) * 1982-06-18 1985-08-20 Bristol-Myers Company Carbapenem antibiotics
FI832619A (fi) * 1982-07-26 1984-01-27 Sandoz Ag Fluoralkylerade karbapenemderivat
NZ205626A (en) * 1982-09-28 1986-12-05 Bristol Myers Co Carbapenem antibiotics
DK140584A (da) * 1983-03-08 1984-09-09 Bristol Myers Co Fremgangsmaade til fremstilling af carbapenemderivater
JPS60202886A (ja) * 1984-03-27 1985-10-14 Sankyo Co Ltd １―置換カルバペネム―３―カルボン酸誘導体

Also Published As

Publication number Publication date
US4665169A (en) 1987-05-12
GB2180238B (en) 1989-09-06
HUT42487A (en) 1987-07-28
NZ217519A (en) 1990-07-26
FI81803B (fi) 1990-08-31
DE3630857C2 (de) 1994-04-07
CN1015261B (zh) 1992-01-01
GR862313B (en) 1987-01-12
IT1207578B (it) 1989-05-25
YU45800B (sh) 1992-07-20
KR870003110A (ko) 1987-04-15
AU596990B2 (en) 1990-05-24
SE8603798D0 (sv) 1986-09-10
AU6234886A (en) 1987-03-12
CS656786A2 (en) 1988-03-15
ES2002303A6 (es) 1988-08-01
HU198491B (en) 1989-10-30
PT83361A (en) 1986-10-01
YU158586A (en) 1988-02-29
FI863609A0 (fi) 1986-09-08
GB8621759D0 (en) 1986-10-15
FI863609A (fi) 1987-03-12
AR242577A1 (es) 1993-04-30
ZW16186A1 (en) 1988-03-30
DD252605A1 (de) 1987-12-23
CS259892B2 (en) 1988-11-15
ZA866638B (en) 1987-05-27
CH669381A5 (zh) 1989-03-15
IT8621666A0 (it) 1986-09-10
AT396472B (de) 1993-09-27
SE469630B (sv) 1993-08-09
KR910006807B1 (ko) 1991-09-02
FI81803C (fi) 1990-12-10
IL79969A0 (en) 1986-12-31
JPS6261980A (ja) 1987-03-18
CN86105933A (zh) 1987-05-20
PT83361B (pt) 1989-05-12
DE3630857A1 (de) 1987-03-19
FR2587704A1 (fr) 1987-03-27
DK433586A (da) 1987-03-12
BE905415A (fr) 1987-03-10
DK433586D0 (da) 1986-09-10
SU1480764A3 (ru) 1989-05-15
SE8603798L (sv) 1987-03-12
ATA245286A (de) 1993-01-15
GB2180238A (en) 1987-03-25
LU86575A1 (fr) 1987-04-02
MY102957A (en) 1993-03-31
FR2587704B1 (fr) 1989-02-24

Similar Documents

Publication Publication Date Title
DE3780344T2 (de) Beta-lactam-verbindungen und deren herstellung.
NL8602282A (nl) Carbapenem-antibiotica.
EP0235823B1 (en) Carbapenem antibiotics, a process for preparing them and pharmaceutical compositions containing them
US4880922A (en) Carbapenems with quaternized heterothioalkylthio substitution at position 2
CA2280273A1 (en) Carbapenem compounds, use thereof, and intermediate compounds of the same
KR910009270B1 (ko) 카바펜엠 항생제의 제조방법
KR880001055B1 (ko) 카르바페넴 유도체의 제조방법
JPH0429675B2 (zh)
JPH0564153B2 (zh)
DD252605A5 (de) Verfahren zur herstellung von carbapenem-antibiotika
JPH0426688A (ja) ２‐アルケニルカルバペネム誘導体

Legal Events

Date Code Title Description
DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: BRISTOL-MYERS SQUIBB COMPANY

BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BV The patent application has lapsed